Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Capitol Hill Briefs

This article was originally published in The Gray Sheet

Executive Summary

FDA approps: The House passes 2010 FDA appropriations July 9, including a $35 million increase for CDRH from last year to well over $300 million. The Agriculture Appropriations Act includes $2.35 billion in total appropriations for FDA, a $299 million bump from 2009, equaling the Obama administration's request (1"The Gray Sheet" June 15, 2009). The Senate Appropriations Committee approved the same funding on July 7, but it still needs to be voted on by the full Senate

You may also be interested in...



Groups Urge HHS To Limit Burden In Conflict Of Interest Reg Proposal

Industry and research organizations are worried that HHS proposals to change financial conflict of interest reporting regulations will cause undue administrative burden for health care research centers and privacy concerns for investigators

Groups Urge HHS To Limit Burden In Conflict Of Interest Reg Proposal

Industry and research organizations are worried that HHS proposals to change financial conflict of interest reporting regulations will cause undue administrative burden for health care research centers and privacy concerns for investigators

FDA appropriations

Senate approves FDA appropriations for fiscal 2010 on Aug. 4, including $315 million for the device center - approximately $35 million more than the center received in FY 2009. Overall, the Senate Agriculture Appropriations Act would give FDA about $2.35 billion in FY 2010, a $299 million increase over the prior year and the same amount approved by the House July 9 (1"The Gray Sheet" July 13, 2009)

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT027646

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel